Latest Market News

Peak Processing has significantly expanded its manufacturing partnership with St. Peter’s Beverages, tripling its SKU production and boosting annual output by up to 700,000 units. This move strengthens its foothold in North America’s cannabis beverage market using proprietary technology.

West Wits Mining has transitioned its Qala Shallows project from mobilisation to underground production, delivering first ore to surface and targeting its first gold pour in March 2026. The company has secured substantial funding to support this milestone and future growth.

InvestSMART Group Limited reported a 2.2% increase in Funds Under Management to $750 million as of December 2025, supported by growth in Professionally Managed Accounts and rising subscription income. The company also extended its Employee and Director Share Plan loans and executed an on-market share buyback.

Impact Minerals has acquired a 55 sq km tenement covering the historic Huonville gold district near Broken Hill, significantly expanding its landholding and advancing its exploration for copper-gold deposits.

WiseTech Global has announced its key financial and governance dates for FY26, highlighting its ongoing commitment to innovation and global logistics software dominance.

Pure Foods Tasmania has launched contract manufacturing with Brilliant Food Australia, marking a significant step in utilising its Woodbridge Smokehouse facility and expanding regional employment.

OD6 Metals has identified a strong off-hole conductor near historic high-grade copper workings at its Gulf Creek project, signalling promising new drill targets. The findings from a recent Down Hole Electromagnetic survey enhance the project’s exploration potential ahead of upcoming drilling.

Visionflex Group’s Q2 FY26 report reveals a 23% rise in annual recurring revenue and improved cash flow, even as overall revenue slips due to lower hardware sales.

Anteris Technologies has completed a $90 million strategic investment from Medtronic as part of a $320 million capital raise, advancing its DurAVR transcatheter heart valve towards global commercialisation and pivotal clinical trials.

Riversgold Ltd has affirmed the material significance of its recent Northern Zone gold exploration results alongside a $2 million capital raising, assuring compliance with ASX continuous disclosure rules.

Rhythm Biosciences has begun commercialising its blood-based colorectal cancer test, ColoSTAT®, following key accreditations and validation. The company also secured a strategic partnership with NHS England and expanded its geneType™ platform globally.

Anteris Technologies has closed a $320 million capital raise, combining a $230 million public offering and a strategic private placement with Medtronic, to advance its DurAVR heart valve clinical trials and manufacturing growth.